Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Release of PYY from pig intestinal mucosa
Therapies based on GLP-1 receptor agonists: significance, challenges, and opportunities 8 March 2026 Ahead of World Obesity Day, colleagues from the World Obesity Federation, International Diabetes Federation, World Heart Federation and the Medicines Patent Pool have published a new openaccess Comment in The Lancet Global Health on: Therapies based on GLP1 receptor agonists: significance, challenges, and opportunities. The paper reflects a turning point in global obesity care
Although it is not approved for human use by any major regulatory body, interest in NNMT inhibition as a research target has driven study of 5-Amino-1MQ in metabolic models
pentapeptide Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH Formula / M.W.: C 38 H 49 N 9 O 5 , ~711.85 g/mol CAS: 170851-70-4 Disclaimer This product is intended for laboratory research use only
US$ 21.60
US$ 25.44
US$ 23.64
US$ 21.21
US$ 25.10
US$ 29.43
